Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer

Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer

BACKGROUND: Oropharyngeal candidiasis is a common infection in patient receiving radiotherapy for head and neckcancer. Accurate and rapid identification of candida species is very important in clinical laboratory, because theincidence of candidiasis continues to rise after radiotherapy. The genus Ca...

Full description

Bibliographic Details
Main Authors:	Maryam Rad DMD, MSc, Seyyed Amin Ayatollahi Mousavi PhD, Shahla Kakoei DDS, MSc, Maryam Bahador MD, Nazila Lashkarizadeh DDS
Format:	Article
Language:	English
Published:	Kerman University of Medical Sciences 2012-04-01
Series:	Journal of Oral Health and Oral Epidemiology
Subjects:	Oropharyngeal candidiasis radiation colonization antifungal drugs cancer
Online Access:	http://johoe.kmu.ac.ir/index.php/johoe/article/view/10/6

Similar Items

Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer
by: Maryam Rad, et al.
Published: (2012-07-01)

Comparative Efficacy and Safety of Antifungal Agents in the Prophylaxis of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis
by: Shamala Gopal Rajadurai, et al.
Published: (2022-03-01)

Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis
by: Shamala Gopal Rajadurai, et al.
Published: (2021-08-01)

Ellagic acid: an alternative for antifungal drugs resistance in HIV/AIDS patients with oropharyngeal candidiasis
by: Satutya Wicaksono, et al.
Published: (2020-10-01)

Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans In Vitro and Exhibits Efficacy against Oropharyngeal Candidiasis
by: Junwen Lei, et al.
Published: (2023-02-01)

Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models
by: Mahmoud A. F. Khalil, et al.
Published: (2022-07-01)

High iron-mediated increased oral fungal burden, oral-to-gut transmission, and changes to pathogenicity of Candida albicans in oropharyngeal candidiasis
by: Aparna Tripathi, et al.
Published: (2022-12-01)

Systematic Genetic Interaction Analysis Identifies a Transcription Factor Circuit Required for Oropharyngeal Candidiasis
by: Norma V. Solis, et al.
Published: (2022-02-01)

Miconazole Nitrate Microparticles in Lidocaine Loaded Films as a Treatment for Oropharyngeal Candidiasis
by: Guillermo Tejada, et al.
Published: (2023-05-01)

Clotrimazole-Loaded Borneol-Based In Situ Forming Gel as Oral Sprays for Oropharyngeal Candidiasis Therapy
by: Nutdanai Lertsuphotvanit, et al.
Published: (2023-05-01)

Features of the Course of the Upper Gastrointestinal Tract Pathology in Patients with Oropharyngeal Candidiasis
by: I.V. Kushnirenko
Published: (2016-04-01)

Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China
by: Yu SY, et al.
Published: (2019-04-01)

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
by: Elena Roselletti, et al.
Published: (2019-07-01)

Molecular identification and antifungal susceptibility testing of Candida species isolated from oral lesions in patients with head and neck cancer undergoing radiotherapy
by: Firoozeh Kermani, et al.
Published: (2021-03-01)

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
by: Yu Shi, et al.
Published: (2020-04-01)

Prevalence and antifungal susceptibility of gastrointestinal candidiasis among diabetic patients: A cross-sectional study
by: Anthony P. Oyom, et al.
Published: (2020-12-01)

Therapeutic Response and Antifungal Susceptibility to Fluconazole in Women with Vulvovaginal Candidiasis
by: Zahra Vahedpoor, et al.
Published: (2022-04-01)

Ethnobotanical study of medicinal plants utilized in the management of candidiasis in Northern Uganda
by: Betty Akwongo, et al.
Published: (2022-10-01)

Molecular Typing of Candida Albicans Isolates Recovered from Human Immunodeficiency Virus (HIV)-Infected Patients with Oropharyngeal Candidiasis
by: Farzad Katiraee, et al.
Published: (2014-03-01)

Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
by: Angel León-Buitimea, et al.
Published: (2021-10-01)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
by: Adane Bitew, et al.
Published: (2018-06-01)

Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats
by: N. Chami, et al.

Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
by: Behnam Honarvar, et al.
Published: (2018-12-01)

Radiation Exposure Perturbs IL-17RA-Mediated Immunity Leading to Changes in Neutrophil Responses That Increase Susceptibility to Oropharyngeal Candidiasis
by: Jessica Saul-McBeth, et al.
Published: (2022-05-01)

Synergistic Antifungal Effect of Fluconazole Combined with ZnO Nanoparticles against Candida albicans Strains from Vaginal Candidiasis
by: Azadeh abedzadeh hajar, et al.
Published: (2020-05-01)

Molecular identification and antifungal susceptibility pattern of Candida species isolated form HIV infected patients with candidiasis
by: Sony Paul, et al.
Published: (2019-03-01)

<i>Candidiasis</i> and Mechanisms of Antifungal Resistance
by: Somanon Bhattacharya, et al.
Published: (2020-06-01)

Speciation and antifungal susceptibility of esophageal candidiasis in cancer patients in a tertiary care hospital in South India
by: J. Abirami Lakshmy, et al.
Published: (2016-01-01)

Pediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children
by: William J. Steinbach
Published: (2016-01-01)

Candida albicans Oropharyngeal Infection Is an Exception to Iron-Based Nutritional Immunity
by: Norma V. Solis, et al.
Published: (2023-04-01)

Detection and antifungal susceptibility testing of oral <i>Candida dubliniensis</i> from human immunodeficiency virus-infected patients
by: Chunchanur Sneha, et al.
Published: (2009-10-01)

Vulvovaginal Candidiasis in Pregnancy—Between Sensitivity and Resistance to Antimycotics
by: Nicoleta-Maricica Maftei, et al.
Published: (2023-07-01)

ORAL CANDIDIASIS AND CURRENT TRENDS IN ITS RATIONAL PHARMACOTHERAPY
by: Devіatkina N. M., et al.
Published: (2022-03-01)

Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles
by: Narges Aslani, et al.
Published: (2021-12-01)

Probiotics for Oral Candidiasis: Critical Appraisal of the Evidence and a Path Forward
by: Linda S. Archambault, et al.
Published: (2022-04-01)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
by: Zahra Golestannejad, et al.
Published: (2022-01-01)

Surveillance of the epidemiology and antifungal susceptibility of invasive candidiasis: A retrospective study from 2016 to 2020 in a teaching hospital in Sousse, Tunisia
by: MAHER BEN BRAHIM, et al.
Published: (2024-02-01)

Six-Year Retrospective Analysis of Epidemiology, Risk Factors, and Antifungal Susceptibilities of Candidiasis from a Tertiary Care Hospital in South China
by: Hazrat Bilal, et al.
Published: (2023-08-01)

New opportunities for complex treatment of oropharyngeal candidiasis in HIV-infected patients in the later stages of the disease
by: Artem O. Charushin, et al.
Published: (2023-02-01)

Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis
by: Ben Y. Parslow, et al.
Published: (2022-06-01)